USAEUROPEViVE
ABOUTSPONSORSHIPFOUNDATION
Logo Hlth
Logo Hlth
03 Nov 2022 | 03:45 PM GMT

Digital Health for the Prediction of Cardiovascular Events

Anchored by:

Tom Wilkinson
Chief Science Officer and Co-Founder
MY MHEALTH

Participants:

Tom Wilkinson Chief Science Officer and Co-FounderMy MHealth
Tom Wilkinson
Chief Science Officer and Co-FounderMy MHealth
Jo Peddhinti AdvisoryHLTH Community
Jo Peddhinti
AdvisoryHLTH Community
Benoit Tyl Medical Advisor, Integrated Care CardiologyBayer AG
Benoit Tyl
Medical Advisor, Integrated Care CardiologyBayer AG
Brandon Salimi Business DevelopmentAmgen
Brandon Salimi
Business DevelopmentAmgen
Claire Donnelly Head of Medical PartnershipsHappitech
Claire Donnelly
Head of Medical PartnershipsHappitech
Elisabeth Tsechanski Digital Innovation HubDaiichi Sankyo Europe
Elisabeth Tsechanski
Digital Innovation HubDaiichi Sankyo Europe
Felicia Vaz Head, Business Strategy & Partner Dev. UKFibriCheck
Felicia Vaz
Head, Business Strategy & Partner Dev. UKFibriCheck
Louise O'Mahony Head of Customer SuccessEXi
Louise O'Mahony
Head of Customer SuccessEXi
Nivee Amin Cardiovascular Digital Health LeadBMS
Nivee Amin
Cardiovascular Digital Health LeadBMS
Patrick Markt-Niederreiter VP Digital ExcellenceDaiichi Sankyo Europe
Patrick Markt-Niederreiter
VP Digital ExcellenceDaiichi Sankyo Europe
Patrick Keenan Digital Health Program Lead - DIGITIVAAstellas Rx+
Patrick Keenan
Digital Health Program Lead - DIGITIVAAstellas Rx+
Paula Salme Sandrak Digital Health Product StrategistBayer AG
Paula Salme Sandrak
Digital Health Product StrategistBayer AG
Philipp Unruh Digital Product ManagerBayer AG
Philipp Unruh
Digital Product ManagerBayer AG
Sandra Nagale Director, AI Partnerships & Digital HealthBoston Scientific
Sandra Nagale
Director, AI Partnerships & Digital HealthBoston Scientific
Steve Peretz Healthcare Practice Lead, Digital ProductsAppnovation
Steve Peretz
Healthcare Practice Lead, Digital ProductsAppnovation

About this Meeting

Cardiovascular diseases (CVD) have been at the forefront of digital health innovations. Digital technologies offer significant opportunities for CVD prevention by promoting lifestyle change and continuous tracking of CVD measures, early diagnosis, individualised management/supportive care and clinical decision support.  

In this meeting, we will focus on the use of digital health tools for the prediction of cardiovascular events. Join this session to know more about: 

  • How can we use digital health for the prediction of cardiovascular events? What digital biomarkers are more efficient in doing so? What is the evidence so far? 
  • What types of wearable devices should be used to predict cardiovascular events? What are the advantages and disadvantages of commoditised (e.g. Apple Watch, Fitbit) vs. specialised wearables? 
  • These solutions could lead to cost reductions. How can payers benefit? How can digital health companies convince payers of the real value in predicting cardiovascular events? 
  • How are these technologies being used to support clinicians? How can they be integrated into their programs and workflows? How can we help physicians and care teams prioritise the alerts to make it less time-consuming?  
  • Technologies for the prediction of cardiovascular events can be recommended by the care team or proactively adopted by patients. How do we activate the care team and/or the patient to start using the solution? How do we ensure long-term engagement? 

We would like to remind you that our meetings are small and intimate sessions with a limited number of seats available, therefore we rely on your attendance and participation to ensure a high quality and valuable meeting for all. If you are confirmed for this meeting we ask if you can please ensure your attendance on the day.